Stay updated on Risdiplam in SMA Infants Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.

Latest updates to the Risdiplam in SMA Infants Clinical Trial page
- Check7 days agoChange DetectedAdded 'Show glossary' feature and updated page metadata (Last Update Submitted that Met QC Criteria: 2026-01-07; Last Update Posted: 2026-01; No FEAR Act Data; Revision: v3.4.0). Older revision data (Revision: v3.3.4) and earlier dates were removed — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays revision v3.3.4, replacing v3.3.3. This appears to be a minor metadata update with no substantive changes to the study content.SummaryDifference0.1%

- Check42 days agoChange DetectedStudy Locations updated to include Florida, New South Wales, São Paulo, and Moscow Oblast; related location entries were adjusted.SummaryDifference0.5%

- Check64 days agoChange DetectedNew timestamp fields such as 'Last Update Posted (Estimated)' and related date updates appear on the page, while the core study details and criteria remain unchanged.SummaryDifference0.3%

- Check71 days agoChange DetectedThe PubMed publications note now states entries are automatically filled from PubMed and may not be about the study, and the revision label has been updated to v3.3.2.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page-wide notice about government funding and NIH operating status has been removed. All study details and content remain unchanged.SummaryDifference0.3%

Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.